The Czech Clinical Research Institute (CCRI) will support patients and physicians in the Czech Republic and Slovakia in accessing innovative treatments by expanding Clinerion’s hospital and patient coverage into those countries. CCRI will also accelerate the development of innovative medications by offering the services and real-world data solutions of Clinerion’s Patient Network Explorer platform.
Czech Clinical Research Institute (CCRI) is a full-service contract research organization providing tailor-made solutions for clinical trials monitoring, project management and Good Clinical Practice auditing services, operating mainly in the Czech Republic and Slovakia. CCRI also offers a wide-ranging portfolio of life sciences consulting services within the areas of pharmacovigilance, quality control, regulatory affairs consulting, data management and medical writing.
CCRI will support the expansion of Clinerion’s hospital network in the Czech Republic and Slovakia, thereby expanding the coverage of patients in Patient Network Explorer in those countries. CCRI will also offer Patient Network Explorer services and solutions for real-world evidence and accelerating clinical trials to clinical research sponsors and academic researchers.
“CCRI is a great match for Clinerion in the Czech Republic and Slovakia, traditionally countries with high medical expertise and infrastructure but low trial participation,” says Ian Rentsch, CEO of Clinerion. “Expanding the coverage of Patient Network Explorer will bring patients in the two countries to greater attention when sponsors are making siting decisions.”
About Clinerion
Clinerion accelerates clinical research and medical access to treatments for patients. We use proprietary technologies for analysis of patient data from our global network of partner hospitals. Clinerion’s Patient Network Explorer radically improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site feasibility evaluation and real-time patient search and identification to match patients to treatments. Our technology solution provides real-world evidence analytics for medical access. Clinerion facilitates the participation of partner hospitals in leading-edge, industry-sponsored trials and time savings in patient recruitment. We create innovative and disruptive fit-for-purpose solutions which enable pharmaceutical companies to shorten patient recruitment and save costs by streamlining operations and leveraging strategic intelligence. Clinerion’s proprietary Big Data analytics technologies leverage real-time data from electronic health records which comply with international patient privacy and data security regulations. Clinerion is a global data technology service company headquartered in Switzerland.
Clinerion website: www.clinerion.com
Clinerion’s Patient Network Explorer: www.clinerion.com/index/OverviewOurSolutions/ClinerionPatientNetworkExplorer
For more information, please contact:
Le Vin Chin
Director, Head of Marketing & Communications
Clinerion Ltd
Elisabethenanlage 11, 4051 Basel, Switzerland
Tel.: +41 61 865 60 54
media@clinerion.com
About Czech Clinical Rearch Institute (CCRI)
Czech Clinical Research Institute (CCRI) is a private-owned; fully independent Prague-based (Czech Republic) full-service CRO with a stable team of employees and freelancers. Our teams have managed clinical trials in Central and Eastern Europe, Western Europe and Americas for over 10 years. With a steadily expanding network of highly qualified clinical research professionals, CCRI specializes in Clinical Trials monitoring and management as well as project-based staffing solutions for phases I through IV.
CCRI website: www.ccri.cz
For more information, please contact:
Tomas Bernard
Managing Director
Czech Clinical Rearch Institute (CCRI)
Divadelní 1554, 272 01 Kladno. Czech Republic
Tel.: +420 605 128 472
tomas.bernard@ccri.cz
